Morphic Holding Inc (MORF)
30.19
-0.20
(-0.66%)
USD |
NASDAQ |
May 07, 10:53
Morphic Total Liabilities (Quarterly): 19.18M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 19.18M |
| December 31, 2023 | 25.49M |
| September 30, 2023 | 20.43M |
| June 30, 2023 | 19.36M |
| March 31, 2023 | 15.43M |
| December 31, 2022 | 19.47M |
| September 30, 2022 | 24.12M |
| June 30, 2022 | 25.88M |
| March 31, 2022 | 83.70M |
| December 31, 2021 | 89.59M |
| September 30, 2021 | 88.40M |
| Date | Value |
|---|---|
| June 30, 2021 | 91.57M |
| March 31, 2021 | 90.67M |
| December 31, 2020 | 97.18M |
| September 30, 2020 | 91.27M |
| June 30, 2020 | 97.08M |
| March 31, 2020 | 101.02M |
| December 31, 2019 | 106.52M |
| September 30, 2019 | 100.73M |
| June 30, 2019 | 244.59M |
| March 31, 2019 | 107.68M |
| December 31, 2018 | 241.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
15.43M
Minimum
Mar 2023
244.59M
Maximum
Jun 2019
72.59M
Average
88.99M
Median
Total Liabilities (Quarterly) Benchmarks
| Keros Therapeutics Inc | 37.81M |
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 682.76M |
| Shareholders Equity (Quarterly) | 663.58M |